Treatment Outcomes of Lobular Granulomatous Mastitis: Impact of Hyperprolactinemia, Diabetes, and Erythema Nodosum—Insights From a 7‐Year Cohort Study
Although more than half of LGM patients experienced no significant improvement, recurrence, or discontinued treatment on prednisone or MTX, however, over a median follow-up of 5 years, approximately 90% of LGM patients achieved complete resolution within a median course of 18 months. The presence of abscesses during treatment and elevated plasma prolactin levels was linked to longer disease duration.
Authors
- Abdollah Firoozi (ORCID: https://orcid.org/0000-0002-3048-5139)
- Maryam Emadzadeh (ORCID: https://orcid.org/0000-0002-1526-3765)
- Marzieh Kazerani (ORCID: https://orcid.org/0000-0002-8089-8900)
- Mina AkbariRad (ORCID: https://orcid.org/0000-0002-1071-7983)
- Fereshte Sheybani (ORCID: https://orcid.org/0000-0002-0766-4286)
- Samaneh Sajjadi
- Sajad Ataei Azimi
- Mahdieh Mottaghi (ORCID: https://orcid.org/0009-0004-4665-5536)
Institutions
- Mashhad University of Medical Sciences (IR)
- Islamic Azad University, Mashhad (IR)
- Ghaem Hospital (IR)
Publication Details
- Journal
- The Breast Journal
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1155/tbj/2672157
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00